2018-2023 Global Malignant Lymphoma Market Report (Status and Outlook)

October 2018 | 116 pages | ID: 25303E6EFAFEN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

In this report, LP Information studies the present scenario (with the base year being 2017) and the growth prospects of global Malignant Lymphoma market for 2018-2023.

Cancers that start anywhere in the body’s lymphatic system are called lymphomas. If they have the ability to spread, they are called malignant. The lymphatic system runs throughout our bodies and is composed of lymphoid tissue, vessels, and fluid. Lymphoid tissue contains lymph nodes, which are part of the immune system. The immune system's job is to produce blood cells and protect against harm from invading germs.
The two main types of malignant lymphoma are Hodgkin lymphoma(also known as Hodgkin disease) and NHL. The two types spread in different ways and respond differently to treatment. When lymphomais of a slow-growing variety, it is referred to as low-grade. Aggressive, fast-growing types are called high-grade. A biopsy can also detect the difference between Hodgkin lymphomaand NHL, as well as their various sub-types. Along with imaging and blood tests, the biopsy results will help doctor determine course of treatment.
Over the next five years, LPI(LP Information) projects that Malignant Lymphoma will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

This report presents a comprehensive overview, market shares and growth opportunities of Malignant Lymphoma market by product type, application, key companies and key regions.

To calculate the market size, LP Information considers value generated from the sales of the following segments:

Segmentation by product type:

• Hodgkin Lymphoma
• Non-Hodgkin Lymphoma

Segmentation by application:

• Pharmaceutical Companies
• Hospitals
• Academic And Research Institutes

We can also provide the customized separate regional or country-level reports, for the following regions:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Spain
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:

• Abbott Laboratories
• Abiogen Pharma
• Actelion Pharmaceuticals
• Bristol-Myers Squibb

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

• To study and analyze the global Malignant Lymphoma market size by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
• To understand the structure of Malignant Lymphoma market by identifying its various subsegments.
• Focuses on the key global Malignant Lymphoma players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
• To analyze the Malignant Lymphoma with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the size of Malignant Lymphoma submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Malignant Lymphoma Market Size 2013-2023
  2.1.2 Malignant Lymphoma Market Size CAGR by Region
2.2 Malignant Lymphoma Segment by Type
  2.2.1 Hodgkin Lymphoma
  2.2.2 Non-Hodgkin Lymphoma
2.3 Malignant Lymphoma Market Size by Type
  2.3.1 Global Malignant Lymphoma Market Size Market Share by Type (2013-2018)
  2.3.2 Global Malignant Lymphoma Market Size Growth Rate by Type (2013-2018)
2.4 Malignant Lymphoma Segment by Application
  2.4.1 Pharmaceutical Companies
  2.4.2 Hospitals
  2.4.3 Academic And Research Institutes
2.5 Malignant Lymphoma Market Size by Application
  2.5.1 Global Malignant Lymphoma Market Size Market Share by Application (2013-2018)
  2.5.2 Global Malignant Lymphoma Market Size Growth Rate by Application (2013-2018)

3 GLOBAL MALIGNANT LYMPHOMA BY PLAYERS

3.1 Global Malignant Lymphoma Market Size Market Share by Players
  3.1.1 Global Malignant Lymphoma Market Size by Players (2016-2018)
  3.1.2 Global Malignant Lymphoma Market Size Market Share by Players (2016-2018)
3.2 Global Malignant Lymphoma Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 MALIGNANT LYMPHOMA BY REGIONS

4.1 Malignant Lymphoma Market Size by Regions
4.2 Americas Malignant Lymphoma Market Size Growth
4.3 APAC Malignant Lymphoma Market Size Growth
4.4 Europe Malignant Lymphoma Market Size Growth
4.5 Middle East & Africa Malignant Lymphoma Market Size Growth

5 AMERICAS

5.1 Americas Malignant Lymphoma Market Size by Countries
5.2 Americas Malignant Lymphoma Market Size by Type
5.3 Americas Malignant Lymphoma Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Malignant Lymphoma Market Size by Countries
6.2 APAC Malignant Lymphoma Market Size by Type
6.3 APAC Malignant Lymphoma Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe Malignant Lymphoma by Countries
7.2 Europe Malignant Lymphoma Market Size by Type
7.3 Europe Malignant Lymphoma Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Malignant Lymphoma by Countries
8.2 Middle East & Africa Malignant Lymphoma Market Size by Type
8.3 Middle East & Africa Malignant Lymphoma Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 GLOBAL MALIGNANT LYMPHOMA MARKET FORECAST

10.1 Global Malignant Lymphoma Market Size Forecast (2018-2023)
10.2 Global Malignant Lymphoma Forecast by Regions
  10.2.1 Global Malignant Lymphoma Forecast by Regions (2018-2023)
  10.2.2 Americas Market Forecast
  10.2.3 APAC Market Forecast
  10.2.4 Europe Market Forecast
  10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
  10.3.1 United States Market Forecast
  10.3.2 Canada Market Forecast
  10.3.3 Mexico Market Forecast
  10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
  10.4.1 China Market Forecast
  10.4.2 Japan Market Forecast
  10.4.3 Korea Market Forecast
  10.4.4 Southeast Asia Market Forecast
  10.4.5 India Market Forecast
  10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
  10.5.1 Germany Market Forecast
  10.5.2 France Market Forecast
  10.5.3 UK Market Forecast
  10.5.4 Italy Market Forecast
  10.5.5 Russia Market Forecast
  10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
  10.6.1 Egypt Market Forecast
  10.6.2 South Africa Market Forecast
  10.6.3 Israel Market Forecast
  10.6.4 Turkey Market Forecast
  10.6.5 GCC Countries Market Forecast
10.7 Global Malignant Lymphoma Forecast by Type
10.8 Global Malignant Lymphoma Forecast by Application

11 KEY PLAYERS ANALYSIS

11.1 Abbott Laboratories
  11.1.1 Company Details
  11.1.2 Malignant Lymphoma Product Offered
  11.1.3 Abbott Laboratories Malignant Lymphoma Revenue, Gross Margin and Market Share (2016-2018)
  11.1.4 Main Business Overview
  11.1.5 Abbott Laboratories News
11.2 Abiogen Pharma
  11.2.1 Company Details
  11.2.2 Malignant Lymphoma Product Offered
  11.2.3 Abiogen Pharma Malignant Lymphoma Revenue, Gross Margin and Market Share (2016-2018)
  11.2.4 Main Business Overview
  11.2.5 Abiogen Pharma News
11.3 Actelion Pharmaceuticals
  11.3.1 Company Details
  11.3.2 Malignant Lymphoma Product Offered
  11.3.3 Actelion Pharmaceuticals Malignant Lymphoma Revenue, Gross Margin and Market Share (2016-2018)
  11.3.4 Main Business Overview
  11.3.5 Actelion Pharmaceuticals News
11.4 Bristol-Myers Squibb
  11.4.1 Company Details
  11.4.2 Malignant Lymphoma Product Offered
  11.4.3 Bristol-Myers Squibb Malignant Lymphoma Revenue, Gross Margin and Market Share (2016-2018)
  11.4.4 Main Business Overview
  11.4.5 Bristol-Myers Squibb News

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Table Product Specifications of Malignant Lymphoma
Figure Malignant Lymphoma Report Years Considered
Figure Market Research Methodology
Figure Global Malignant Lymphoma Market Size Growth Rate 2013-2023 ($ Millions)
Table Malignant Lymphoma Market Size CAGR by Region 2013-2023 ($ Millions)
Table Major Players of Hodgkin Lymphoma
Table Major Players of Non-Hodgkin Lymphoma
Table Market Size by Type (2013-2018) ($ Millions)
Table Global Malignant Lymphoma Market Size Market Share by Type (2013-2018)
Figure Global Malignant Lymphoma Market Size Market Share by Type (2013-2018)
Figure Global Hodgkin Lymphoma Market Size Growth Rate
Figure Global Non-Hodgkin Lymphoma Market Size Growth Rate
Figure Malignant Lymphoma Consumed in Pharmaceutical Companies
Figure Global Malignant Lymphoma Market: Pharmaceutical Companies (2013-2018) ($ Millions)
Figure Global Pharmaceutical Companies YoY Growth ($ Millions)
Figure Malignant Lymphoma Consumed in Hospitals
Figure Global Malignant Lymphoma Market: Hospitals (2013-2018) ($ Millions)
Figure Global Hospitals YoY Growth ($ Millions)
Figure Malignant Lymphoma Consumed in Academic And Research Institutes
Figure Global Malignant Lymphoma Market: Academic And Research Institutes (2013-2018) ($ Millions)
Figure Global Academic And Research Institutes YoY Growth ($ Millions)
Table Global Malignant Lymphoma Market Size by Application (2013-2018) ($ Millions)
Table Global Malignant Lymphoma Market Size Market Share by Application (2013-2018)
Figure Global Malignant Lymphoma Market Size Market Share by Application (2013-2018)
Figure Global Malignant Lymphoma Market Size in Pharmaceutical Companies Growth Rate
Figure Global Malignant Lymphoma Market Size in Hospitals Growth Rate
Figure Global Malignant Lymphoma Market Size in Academic And Research Institutes Growth Rate
Table Global Malignant Lymphoma Revenue by Players (2016-2018) ($ Millions)
Table Global Malignant Lymphoma Revenue Market Share by Players (2016-2018)
Figure Global Malignant Lymphoma Revenue Market Share by Players in 2017
Table Global Malignant Lymphoma Key Players Head office and Products Offered
Table Malignant Lymphoma Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Malignant Lymphoma Market Size by Regions 2013-2018 ($ Millions)
Table Global Malignant Lymphoma Market Size Market Share by Regions 2013-2018
Figure Global Malignant Lymphoma Market Size Market Share by Regions 2013-2018
Figure Americas Malignant Lymphoma Market Size 2013-2018 ($ Millions)
Figure APAC Malignant Lymphoma Market Size 2013-2018 ($ Millions)
Figure Europe Malignant Lymphoma Market Size 2013-2018 ($ Millions)
Figure Middle East & Africa Malignant Lymphoma Market Size 2013-2018 ($ Millions)
Table Americas Malignant Lymphoma Market Size by Countries (2013-2018) ($ Millions)
Table Americas Malignant Lymphoma Market Size Market Share by Countries (2013-2018)
Figure Americas Malignant Lymphoma Market Size Market Share by Countries in 2017
Table Americas Malignant Lymphoma Market Size by Type (2013-2018) ($ Millions)
Table Americas Malignant Lymphoma Market Size Market Share by Type (2013-2018)
Figure Americas Malignant Lymphoma Market Size Market Share by Type in 2017
Table Americas Malignant Lymphoma Market Size by Application (2013-2018) ($ Millions)
Table Americas Malignant Lymphoma Market Size Market Share by Application (2013-2018)
Figure Americas Malignant Lymphoma Market Size Market Share by Application in 2017
Figure United States Malignant Lymphoma Market Size Growth 2013-2018 ($ Millions)
Figure Canada Malignant Lymphoma Market Size Growth 2013-2018 ($ Millions)
Figure Mexico Malignant Lymphoma Market Size Growth 2013-2018 ($ Millions)
Table APAC Malignant Lymphoma Market Size by Countries (2013-2018) ($ Millions)
Table APAC Malignant Lymphoma Market Size Market Share by Countries (2013-2018)
Figure APAC Malignant Lymphoma Market Size Market Share by Countries in 2017
Table APAC Malignant Lymphoma Market Size by Type (2013-2018) ($ Millions)
Table APAC Malignant Lymphoma Market Size Market Share by Type (2013-2018)
Figure APAC Malignant Lymphoma Market Size Market Share by Type in 2017
Table APAC Malignant Lymphoma Market Size by Application (2013-2018) ($ Millions)
Table APAC Malignant Lymphoma Market Size Market Share by Application (2013-2018)
Figure APAC Malignant Lymphoma Market Size Market Share by Application in 2017
Figure China Malignant Lymphoma Market Size Growth 2013-2018 ($ Millions)
Figure Japan Malignant Lymphoma Market Size Growth 2013-2018 ($ Millions)
Figure Korea Malignant Lymphoma Market Size Growth 2013-2018 ($ Millions)
Figure Southeast Asia Malignant Lymphoma Market Size Growth 2013-2018 ($ Millions)
Figure India Malignant Lymphoma Market Size Growth 2013-2018 ($ Millions)
Figure Australia Malignant Lymphoma Market Size Growth 2013-2018 ($ Millions)
Table Europe Malignant Lymphoma Market Size by Countries (2013-2018) ($ Millions)
Table Europe Malignant Lymphoma Market Size Market Share by Countries (2013-2018)
Figure Europe Malignant Lymphoma Market Size Market Share by Countries in 2017
Table Europe Malignant Lymphoma Market Size by Type (2013-2018) ($ Millions)
Table Europe Malignant Lymphoma Market Size Market Share by Type (2013-2018)
Figure Europe Malignant Lymphoma Market Size Market Share by Type in 2017
Table Europe Malignant Lymphoma Market Size by Application (2013-2018) ($ Millions)
Table Europe Malignant Lymphoma Market Size Market Share by Application (2013-2018)
Figure Europe Malignant Lymphoma Market Size Market Share by Application in 2017
Figure Germany Malignant Lymphoma Market Size Growth 2013-2018 ($ Millions)
Figure France Malignant Lymphoma Market Size Growth 2013-2018 ($ Millions)
Figure UK Malignant Lymphoma Market Size Growth 2013-2018 ($ Millions)
Figure Italy Malignant Lymphoma Market Size Growth 2013-2018 ($ Millions)
Figure Russia Malignant Lymphoma Market Size Growth 2013-2018 ($ Millions)
Figure Spain Malignant Lymphoma Market Size Growth 2013-2018 ($ Millions)
Table Middle East & Africa Malignant Lymphoma Market Size by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Malignant Lymphoma Market Size Market Share by Countries (2013-2018)
Figure Middle East & Africa Malignant Lymphoma Market Size Market Share by Countries in 2017
Table Middle East & Africa Malignant Lymphoma Market Size by Type (2013-2018) ($ Millions)
Table Middle East & Africa Malignant Lymphoma Market Size Market Share by Type (2013-2018)
Figure Middle East & Africa Malignant Lymphoma Market Size Market Share by Type in 2017
Table Middle East & Africa Malignant Lymphoma Market Size by Application (2013-2018) ($ Millions)
Table Middle East & Africa Malignant Lymphoma Market Size Market Share by Application (2013-2018)
Figure Middle East & Africa Malignant Lymphoma Market Size Market Share by Application in 2017
Figure Egypt Malignant Lymphoma Market Size Growth 2013-2018 ($ Millions)
Figure South Africa Malignant Lymphoma Market Size Growth 2013-2018 ($ Millions)
Figure Israel Malignant Lymphoma Market Size Growth 2013-2018 ($ Millions)
Figure Turkey Malignant Lymphoma Market Size Growth 2013-2018 ($ Millions)
Figure GCC Countries Malignant Lymphoma Market Size Growth 2013-2018 ($ Millions)
Figure Global Malignant Lymphoma arket Size Forecast (2018-2023) ($ Millions)
Table Global Malignant Lymphoma Market Size Forecast by Regions (2018-2023) ($ Millions)
Table Global Malignant Lymphoma Market Size Market Share Forecast by Regions
Figure Americas Malignant Lymphoma Market Size 2018-2023 ($ Millions)
Figure APAC Malignant Lymphoma Market Size 2018-2023 ($ Millions)
Figure Europe Malignant Lymphoma Market Size 2018-2023 ($ Millions)
Figure Middle East & Africa Malignant Lymphoma Market Size 2018-2023 ($ Millions)
Figure United States Malignant Lymphoma Market Size 2018-2023 ($ Millions)
Figure Canada Malignant Lymphoma Market Size 2018-2023 ($ Millions)
Figure Mexico Malignant Lymphoma Market Size 2018-2023 ($ Millions)
Figure Brazil Malignant Lymphoma Market Size 2018-2023 ($ Millions)
Figure China Malignant Lymphoma Market Size 2018-2023 ($ Millions)
Figure Japan Malignant Lymphoma Market Size 2018-2023 ($ Millions)
Figure Korea Malignant Lymphoma Market Size 2018-2023 ($ Millions)
Figure Southeast Asia Malignant Lymphoma Market Size 2018-2023 ($ Millions)
Figure India Malignant Lymphoma Market Size 2018-2023 ($ Millions)
Figure Australia Malignant Lymphoma Market Size 2018-2023 ($ Millions)
Figure Germany Malignant Lymphoma Market Size 2018-2023 ($ Millions)
Figure France Malignant Lymphoma Market Size 2018-2023 ($ Millions)
Figure UK Malignant Lymphoma Market Size 2018-2023 ($ Millions)
Figure Italy Malignant Lymphoma Market Size 2018-2023 ($ Millions)
Figure Russia Malignant Lymphoma Market Size 2018-2023 ($ Millions)
Figure Spain Malignant Lymphoma Market Size 2018-2023 ($ Millions)
Figure Egypt Malignant Lymphoma Market Size 2018-2023 ($ Millions)
Figure South Africa Malignant Lymphoma Market Size 2018-2023 ($ Millions)
Figure Israel Malignant Lymphoma Market Size 2018-2023 ($ Millions)
Figure Turkey Malignant Lymphoma Market Size 2018-2023 ($ Millions)
Figure GCC Countries Malignant Lymphoma Market Size 2018-2023 ($ Millions)
Table Global Malignant Lymphoma Market Size Forecast by Type (2018-2023) ($ Millions)
Table Global Malignant Lymphoma Market Size Market Share Forecast by Type (2018-2023)
Table Global Malignant Lymphoma Market Size Forecast by Application (2018-2023) ($ Millions)
Table Global Malignant Lymphoma Market Size Market Share Forecast by Application (2018-2023)
Table Abbott Laboratories Basic Information, Head Office, Major Market Areas and Its Competitors
Table Abbott Laboratories Malignant Lymphoma Revenue and Gross Margin (2016-2018)
Figure Abbott Laboratories Malignant Lymphoma Market Share (2016-2018)
Table Abiogen Pharma Basic Information, Head Office, Major Market Areas and Its Competitors
Table Abiogen Pharma Malignant Lymphoma Revenue and Gross Margin (2016-2018)
Figure Abiogen Pharma Malignant Lymphoma Market Share (2016-2018)
Table Actelion Pharmaceuticals Basic Information, Head Office, Major Market Areas and Its Competitors
Table Actelion Pharmaceuticals Malignant Lymphoma Revenue and Gross Margin (2016-2018)
Figure Actelion Pharmaceuticals Malignant Lymphoma Market Share (2016-2018)
Table Bristol-Myers Squibb Basic Information, Head Office, Major Market Areas and Its Competitors
Table Bristol-Myers Squibb Malignant Lymphoma Revenue and Gross Margin (2016-2018)
Figure Bristol-Myers Squibb Malignant Lymphoma Market Share (2016-2018)